ArticleEBioMedicine2015

Inhibition of ERBB2-overexpressing Tumors by Recombinant Human Prolidase and Its Enzymatically Inactive Mutant.

Lu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.